申请人:Flygare John A.
公开号:US20110077265A1
公开(公告)日:2011-03-31
The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds having the general formula U1-M-U2 wherein M is a linking group covalently joining R2, R3, R4 or R5 of U1 to an R2, R3, R4 or R5 group of U2; U1 and U2 have the general formula (I) and G, X1, X2, R2, R3, R3′, R4, R4′ and R5, are as described herein.
本发明提供了IAP的新型抑制剂,可用作治疗恶性肿瘤的治疗剂,其中化合物具有一般式U1-M-U2,其中M是连接U1的R2、R3、R4或R5与U2的R2、R3、R4或R5基团的连接基团;U1和U2具有一般式(I),G、X1、X2、R2、R3、R3'、R4、R4'和R5如本文所述。